Profile Picture
Rewards
  • Search
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
    • Real Estate
    • My Bing
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Calls Swift 'Kelce's wife'
‘I am insecure’
Priest stabbed to death
Dropped by 18 brands
Cardi B confirms split
Defamation suit goes to trial
Netanyahu speaks to Putin
Kids accept Nobel Prize
Has non-Hodgkin's lymphoma
Horse killed, 4 hurt in crash
Tanks enter Khan Younis
$43M+ overseas debut
AU to cut migrant intake
Needs $46B for aid in '24
Suffers right hand fracture
US F-16 jet crashes in SK
To invest $1.5B in GoTo
Bills beat Chiefs 20-17
Receives $5B+ buyout offer?
Stabbing at DC jail injures 3
Rangers beat Kings 4-1
Stephanie Pope as new COO
1-year, $4 million deal
James makes USC debut
UK sends 2 minehunters
Named Browns starting QB
To start military service
Capitals defeat Blackhawks
Attends Milei's inauguration
Former Ky. governor dies
Teases ‘White Lotus’ S3
Top search trends for 2023
Cigna shares jump
California hiker rescued
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
25,100 results
7h
This Week in Chancery Court: AstraZeneca Faces Bullying Claims
The British pharmaceutical giant AstraZeneca Plc will argue before Delaware’s Court of Chancery this week that claims it ...
Proactiveinvestors1mon
AstraZeneca faces lawsuits in High Court over ‘defective’ Covid-19 vaccine
Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced ...
Bournemouth Daily Echo2mon
AstraZeneca settles heartburn drug legal claims for £352m
Drugs giant AstraZeneca has agreed to settle a raft of legal claims over its heartburn treatments for 425 million US dollars (£352 million). The FTSE 100 listed firm said the agreements will ...
3hon MSN
AstraZeneca's Investigational Drug Shows Durable Clinical Benefit In Patients With Rare Blood Disease
AstraZeneca Plc (NASDAQ: AZN) released results from the 24-week and long-term extension (LTE) period of the ALPHA Phase 3 ...
Proactive Investors1mon
AstraZeneca faces lawsuits in High Court over ‘defective’ Covid-19 vaccine
Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Get the Bing App
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices